【24h】

Polymetalacrylates as a new generation of local action hemostatics combining effective stop-bleeding,antimicrobial,wound-and burn-healing effects

机译:多金属丙烯酸酯作为新一代局部止血剂,具有有效的止血,抗菌,伤口和烧伤愈合作用

获取原文
获取原文并翻译 | 示例

摘要

1.Introduction In 1970s, the original local action hemostatie FERACRYL combining stop-bleeding, antimicrobial, wound-healing and analgesic actions has been developed and patented at the Irkutsk Institute of Organic Chemistry, Siberian Branch, USSR Academy of Sciences [1-4]. Afterwards its technological methods has been elaborated and its industrial large-scale production has been realized successfully, so it has been used in many countries (as HEMOLOCK in some places). FERACRYL is incomplete ferric salt of polyacrylie acid (PAA) with iron content of 2.5% Fe2+ and Fe3+. It has been established that bemostatic effect of FERACRYL and stability of the clot formed by its interaction with blood plasma proteins increases with the growth of the iron content in it. We have failed to increase the iron content more then 2.5%.
机译:1.简介1970年代,最初的局部止血FERACRYL结合了止血,抗菌,伤口愈合和止痛作用,已在苏联科学院西伯利亚分校伊尔库茨克有机化学研究所开发并申请了专利[1-4] 。之后详细阐述了其技术方法,并成功实现了工业化大规模生产,因此已在许多国家/地区使用(在某些地方用作HEMOLOCK)。 FERACRYL是聚丙烯酸(PAA)的不完全铁盐,铁含量为2.5%Fe2 +和Fe3 +。已经确定,FERACRYL的止血作用和由其与血浆蛋白相互作用形成的凝块的稳定性随着其中铁含量的增加而增加。我们未能将铁含量提高到2.5%以上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号